Subscribe to MDT Magazine News

Volcano Reports Record Revenue and GAAP Profitability for 2010

February 23, 2011 10:33 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 23, 2011 /- Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, today reported record revenues for the...


Prevalence of bunions increases with age; more common in women

February 23, 2011 7:37 pm | by EurekAlert | Comments

(Wiley-Blackwell) New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life. Bunion deformity was found in 36 percent of the study population and occurred more...


Monocrystal ships 8-inch C-plane sapphire substrates to leading LED maker

February 23, 2011 7:36 pm | by I-Micronews | Comments

Monocrystal, announced the shipment of its premium 8-inch C-plane epi-ready sapphire substrates to what the company says is one of the world?s leading LED manufacturers.


Transphorm emerges from stealth to redefine energy efficiency

February 23, 2011 7:36 pm | by I-Micronews | Comments

Company backed by $38 million from leading venture capital firms Kleiner Perkins, Google Ventures, Foundation Capital, and Lux Capital.

Social Networking's Newest Friend: Genomics

February 23, 2011 7:33 pm | by Massachusetts Institute of Technology | Comments

The first large-scale study to combine genome sequencing and social-network analysis solves a mysterious TB outbreak.


Serious Eye Disease Gives Birth to Invention of Major New Eye Care Device

February 23, 2011 5:35 pm | by Bio-Medicine.Org | Comments

ORLANDO, Fla., Feb. 23, 2011 /- The Eye-POD-Eye-Care-Kit was created by a Doctor who suffered a serious eye malady, Bells-Palsy. Inventor Dr. Courtenay created the Eye ~ POD™ to answer his struggles with dry eyes, a side effect of Bells-Palsy. The affliction was caused by scratching...


New vaccine technology protects mice from hepatitis C virus

February 23, 2011 1:37 pm | by EurekAlert | Comments

(University of Copenhagen) HCV mutates so strongly that traditional vaccines are useless. However, University of Copenhagen researchers are the first to succeed in developing a vaccine, which provides future hope for medical protection from the hepatitis C virus.


Support the Have a HeArt Benefit, Feb. 25

February 23, 2011 12:35 pm | by Arizona State University | Comments

ASU's College of Nursing & Health Innovation is hosting a "Have a HeART Benefit," Feb. 25, with proceeds going to the College's NP Healthcare more


Review highlights need for more education and guidance on CAM use in midwifery

February 23, 2011 10:38 am | by EurekAlert | Comments

(Wiley-Blackwell) Complementary and alternative medicine is increasingly popular in maternity care, but health care professionals need formal evidence-based education and guidance about its use. University-based members of the Network of Researchers in the Public Health of...


ViewRay Receives FDA 510(k) Marketing Clearance for Treatment Planning and Delivery Software

February 23, 2011 10:36 am | by Bio-Medicine.Org | Comments

CLEVELAND, Feb. 23, 2011 /- ViewRay™, Inc., a privately held medical device company, has received U.S. FDA marketing clearance for its radiotherapy treatment planning and delivery software. The software is a critical component of the company's new radiation therapy system, which...


Extenze Tablets: Recall

February 23, 2011 10:31 am | by U.S. Food & Drug Administration | Comments

Counterfeit dietary supplement contains tadalafil, sildenafil, and/or sibutramine, which may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.


Synovis 1Q profit jumps on surgical product sales

February 23, 2011 9:45 am | by The Associated Press | Comments

Medical device maker Synovis Life Technologies Inc. said Wednesday its fiscal first-quarter profit nearly tripled on a boost in sales of its key surgical products.The company earned $1.8 million, or 16 cents per share, up from $643,000, or 6 cents per share, during the same period a year prior....

Neurocrine Biosciences to Present at Citi's 2011 Global Health Care Conference

February 23, 2011 9:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 23, 2011 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at Citi's 2011 Global Health Care Conference in New York.   The live presentation takes...


Dave Anderson and William Thomsen Join SRI International's Center for Advanced Drug Research to Lead Programs in Proteomics and Metabolic Disease Drug Discovery

February 23, 2011 9:34 am | by Bio-Medicine.Org | Comments

MENLO PARK, Calif., Feb. 23, 2011 /- SRI International, an independent nonprofit research and development organization, announced today that two new principal scientists, Dave Anderson, Ph.D., and William Thomsen, Ph.D., have joined its Center for Advanced Drug Research (CADRE) in...


Vertex sees positive data from Phase 3 CF study

February 23, 2011 9:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Vertex Pharmaceuticals Inc. of Cambridge today released results of a Phase 3 study of its VX-770 drug candidate for a specific type of cystic fibrosis (CF) that showed a relative mean improvement in lung function of about 17 percent over placebo.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.